In both cohorts, atypical parkinsonian disorders (e.g., CBS, PSP, MSA) had substantial increases in plasma NfL as compared to PD with very high diagnostic accuracies (KCL, AUC > 86%; Lund, AUC > 95%) and large effect sizes. The gene discussed is NEFL; the disease is multiple system atrophy.